USD 1.81
(-2.16%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 8.4 Million USD | 73.13% |
2022 | 4.73 Million USD | -17.62% |
2021 | 5.74 Million USD | 16.89% |
2020 | 4.91 Million USD | -19.25% |
2019 | 6.08 Million USD | 89.95% |
2018 | 3.2 Million USD | 39.75% |
2017 | 2.29 Million USD | 77.13% |
2016 | 1.29 Million USD | 22.08% |
2015 | 1.06 Million USD | -11.59% |
2014 | 1.19 Million USD | 42.4% |
2013 | 842 Thousand USD | -21.31% |
2012 | 1.07 Million USD | 23.27% |
2011 | 868 Thousand USD | -22.64% |
2010 | 1.12 Million USD | 22.36% |
2009 | 917 Thousand USD | 124.21% |
2008 | 409 Thousand USD | 27.81% |
2007 | 320 Thousand USD | 313.0% |
2006 | -150.23 Thousand USD | -107.35% |
2005 | 2.04 Million USD | 2880.98% |
2004 | -73.53 Thousand USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | -100.0% |
2001 | 300 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 2.15 Million USD | 9.34% |
2024 Q2 | 1.87 Million USD | -12.81% |
2023 Q1 | 2.11 Million USD | 39.89% |
2023 FY | 8.19 Million USD | 73.13% |
2023 Q4 | 1.97 Million USD | -10.21% |
2023 Q3 | 2.19 Million USD | 5.53% |
2023 Q2 | 2.07 Million USD | -1.52% |
2022 Q2 | 1.36 Million USD | 32.78% |
2022 Q1 | 1.02 Million USD | -30.22% |
2022 FY | 4.73 Million USD | -17.62% |
2022 Q4 | 1.5 Million USD | 98.03% |
2022 Q3 | 762 Thousand USD | -44.01% |
2021 Q1 | 1.58 Million USD | 21.89% |
2021 Q2 | 1.27 Million USD | -19.66% |
2021 Q3 | 1.41 Million USD | 10.75% |
2021 Q4 | 1.46 Million USD | 4.04% |
2021 FY | 5.74 Million USD | 16.89% |
2020 Q3 | 1.22 Million USD | 36.87% |
2020 Q2 | 895 Thousand USD | -39.97% |
2020 FY | 4.91 Million USD | -19.25% |
2020 Q4 | 1.3 Million USD | 6.29% |
2020 Q1 | 1.49 Million USD | -21.53% |
2019 Q4 | 1.9 Million USD | 4.45% |
2019 Q3 | 1.81 Million USD | 33.07% |
2019 FY | 6.08 Million USD | 89.95% |
2019 Q2 | 1.36 Million USD | 36.97% |
2019 Q1 | 998 Thousand USD | 4.61% |
2018 Q1 | 467 Thousand USD | -40.74% |
2018 FY | 3.2 Million USD | 39.75% |
2018 Q4 | 954 Thousand USD | 0.21% |
2018 Q3 | 952 Thousand USD | 14.7% |
2018 Q2 | 830 Thousand USD | 77.73% |
2017 Q1 | 455 Thousand USD | 17.88% |
2017 FY | 2.29 Million USD | 77.13% |
2017 Q4 | 788 Thousand USD | 48.12% |
2017 Q3 | 532 Thousand USD | 2.9% |
2017 Q2 | 517 Thousand USD | 13.63% |
2016 Q3 | 316 Thousand USD | 6.4% |
2016 Q1 | 295 Thousand USD | 16.6% |
2016 Q2 | 297 Thousand USD | 0.68% |
2016 Q4 | 386 Thousand USD | 22.15% |
2016 FY | 1.29 Million USD | 22.08% |
2015 Q3 | 166 Thousand USD | -53.63% |
2015 Q2 | 358 Thousand USD | 26.95% |
2015 FY | 1.06 Million USD | -11.59% |
2015 Q4 | 253 Thousand USD | 52.41% |
2015 Q1 | 282 Thousand USD | 30.56% |
2014 Q4 | 216 Thousand USD | -31.65% |
2014 FY | 1.19 Million USD | 42.4% |
2014 Q3 | 316 Thousand USD | 5.69% |
2014 Q2 | 299 Thousand USD | -18.53% |
2014 Q1 | 367 Thousand USD | 691.94% |
2013 FY | 842 Thousand USD | -21.31% |
2013 Q3 | 229 Thousand USD | -34.38% |
2013 Q2 | 349 Thousand USD | 7.38% |
2013 Q4 | -62 Thousand USD | -127.07% |
2013 Q1 | 325 Thousand USD | 311.39% |
2012 Q1 | 311 Thousand USD | 98.09% |
2012 FY | 1.07 Million USD | 23.27% |
2012 Q3 | 413 Thousand USD | 54.68% |
2012 Q4 | 79 Thousand USD | -80.87% |
2012 Q2 | 267 Thousand USD | -14.15% |
2011 Q1 | 199 Thousand USD | 35.37% |
2011 Q2 | 203 Thousand USD | 2.01% |
2011 Q4 | 157 Thousand USD | -49.19% |
2011 Q3 | 309 Thousand USD | 52.22% |
2011 FY | 868 Thousand USD | -22.64% |
2010 Q1 | 389 Thousand USD | 30.1% |
2010 Q3 | 303 Thousand USD | 7.45% |
2010 Q4 | 147 Thousand USD | -51.49% |
2010 FY | 1.12 Million USD | 22.36% |
2010 Q2 | 282 Thousand USD | -27.51% |
2009 Q2 | 191 Thousand USD | 6.7% |
2009 FY | 917 Thousand USD | 124.21% |
2009 Q4 | 299 Thousand USD | 20.56% |
2009 Q1 | 179 Thousand USD | 496.67% |
2009 Q3 | 248 Thousand USD | 29.84% |
2008 Q4 | 30 Thousand USD | -78.42% |
2008 FY | 409 Thousand USD | 27.81% |
2008 Q1 | 149 Thousand USD | 2.05% |
2008 Q2 | 91 Thousand USD | -38.93% |
2008 Q3 | 139 Thousand USD | 52.75% |
2007 Q2 | 103 Thousand USD | 13.19% |
2007 Q4 | 146 Thousand USD | 868.42% |
2007 Q3 | -19 Thousand USD | -118.45% |
2007 FY | 320 Thousand USD | 313.0% |
2007 Q1 | 91 Thousand USD | 370.89% |
2006 FY | -150.23 Thousand USD | -107.35% |
2006 Q3 | -38.14 Thousand USD | 76.08% |
2006 Q4 | 19.32 Thousand USD | 150.67% |
2006 Q1 | 28.02 Thousand USD | -69.67% |
2006 Q2 | -159.44 Thousand USD | -669.03% |
2005 Q3 | 73.6 Thousand USD | -34.72% |
2005 Q4 | 92.37 Thousand USD | 25.51% |
2005 Q1 | 1.76 Million USD | 12329.43% |
2005 Q2 | 112.74 Thousand USD | -93.62% |
2005 FY | 2.04 Million USD | 2880.98% |
2004 Q4 | -14.44 Thousand USD | -284.48% |
2004 Q2 | -33.46 Thousand USD | 0.0% |
2004 FY | -73.53 Thousand USD | 0.0% |
2004 Q3 | 7829.00 USD | 123.4% |
2003 FY | - USD | 0.0% |
2002 FY | - USD | -100.0% |
2001 FY | 300 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Akoya Biosciences, Inc. | 56.3 Million USD | 85.072% |
AngioDynamics, Inc. | 154.69 Million USD | 94.567% |
AtriCure, Inc. | 300.37 Million USD | 97.202% |
Avinger, Inc. | 2 Million USD | -319.621% |
Azenta, Inc. | 263.14 Million USD | 96.806% |
BioLife Solutions, Inc. | 46.75 Million USD | 82.022% |
The Cooper Companies, Inc. | 2.35 Billion USD | 99.644% |
Daxor Corporation | 1.1 Million USD | -661.709% |
Ekso Bionics Holdings, Inc. | 9.07 Million USD | 7.424% |
Femasys Inc. | 691.9 Thousand USD | -1114.769% |
GlucoTrack, Inc. | -13 Thousand USD | 64753.846% |
Harvard Bioscience, Inc. | 60.86 Million USD | 86.191% |
Hologic, Inc. | 2.22 Billion USD | 99.623% |
ICU Medical, Inc. | 739.87 Million USD | 98.864% |
Intuitive Surgical, Inc. | 4.72 Billion USD | 99.822% |
KORU Medical Systems, Inc. | 16.7 Million USD | 49.696% |
LeMaitre Vascular, Inc. | 127.04 Million USD | 93.384% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 7143.552% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 7143.552% |
Masimo Corporation | 1 Billion USD | 99.162% |
Microbot Medical Inc. | -106 Thousand USD | 8029.245% |
Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 74.603% |
Merit Medical Systems, Inc. | 583.87 Million USD | 98.56% |
NovoCure Limited | 381.05 Million USD | 97.794% |
NEXGEL, Inc. | 619 Thousand USD | -1257.835% |
NEXGEL, Inc. | 619 Thousand USD | -1257.835% |
Singular Genomics Systems, Inc. | -558 Thousand USD | 1606.272% |
OraSure Technologies, Inc. | 179.42 Million USD | 95.315% |
Pro-Dex, Inc. | 14.55 Million USD | 42.238% |
Pulse Biosciences, Inc. | -1.2 Million USD | 796.355% |
Predictive Oncology Inc. | 1.14 Million USD | -633.871% |
Precision Optics Corporation, Inc. | 5.79 Million USD | -44.969% |
QuidelOrtho Corporation | 1.49 Billion USD | 99.438% |
Repligen Corporation | 315.22 Million USD | 97.334% |
Sanara MedTech Inc. | 57.13 Million USD | 85.29% |
STAAR Surgical Company | 252.65 Million USD | 96.673% |
Sharps Technology, Inc. | -891.24 Thousand USD | 1043.06% |
Utah Medical Products, Inc. | 30.03 Million USD | 72.019% |
DENTSPLY SIRONA Inc. | 2.08 Billion USD | 99.597% |
Jin Medical International Ltd. | 6.78 Million USD | -23.879% |